** daily **
Albany Molecular Research, Inc., a contract research and manufacturing organization, offers drug discovery, development, and manufacturing services to pharmaceutical and biotechnology companies in the United States, Europe, and Asia. The company offers drug discovery services, including assay development and design, screening, screening library, natural product, custom synthesis and library synthesis, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services comprising process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services; and chemical synthesis and manufacturing services. In addition, it offers contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals; and formulation services, such as aseptic fill and finish, aseptic lyophilization, neat active pharmaceutical ingredients or pharmaceutical blend in capsules, powder in bottle for solution and suspension, blending and sieving, milling, tableting, rheology, roller compaction, wet granulation, and fluid bed processing, as well as associated analytical testing services. Further, the company provides analytical chemistry services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; laboratory practices bioanalytical services; and regulatory support/quality assurance services.
The company was founded in 1991 and is headquartered in Albany, New York.
** daily **
Address
26 Corporate Circle
ALBANY, NY 12212
United States
ALBANY, NY 12212
United States
Website
http://www.amriglobal.comKey stats and ratios
| Q4 (Dec '13) | 2013 | |
| Net profit margin | 6.69% | 5.14% |
| Operating margin | 10.38% | 8.18% |
| EBITD margin | - | 11.85% |
| Return on average assets | - | - |
| Return on average equity | - | - |
| Employees | 1,329 |
No comments:
Post a Comment